Skip to main content
Daesung Microbiological Labs. Co. Ltd logo

Daesung Microbiological Labs. Co. Ltd — Investor Relations & Filings

Ticker · 036480 ISIN · KR7036480002 KO Manufacturing
Open in API
Filings indexed 126 across all filing types
Latest filing 2019-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 036480

About Daesung Microbiological Labs. Co. Ltd

https://eng.dsmbio.co.kr/

Daesung Microbiological Labs. Co., Ltd. is a company specializing in the development, manufacturing, and distribution of animal pharmaceuticals. Established in 1968, it is a leading vaccine manufacturer operating under KVGMP (Korean Veterinary Good Manufacturing Practice) standards. The company's product portfolio includes a comprehensive range of vaccines, antibiotics, parasiticides, and nutritional supplements. These products are designed for the health and well-being of livestock such as swine, bovine, and poultry, as well as for companion animals like canines. Daesung Microbiological Labs is committed to achieving disease-free livestock through continuous research and technological innovation in animal health.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for (주)대성미생물연구소. It contains the agenda for the upcoming Annual General Meeting (AGM), including reports on financial statements, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, etc.) as part of the 'Management Reference' (경영참고사항) required for shareholders to review before the meeting. This is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes.
2019-03-13 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting (주주총회소집결의) issued by Daesung Microbiological Labs. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including financial statement approval, director appointments, and remuneration limits. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on meeting agenda items.
2019-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Daesung Microbiological Labs) announcing a significant change (over 15-30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides key financial highlights and profit structure changes rather than a full annual report or a simple report publication notice, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance metrics. FY 2018
2019-02-12 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Daesung Microbiological Labs regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend yield, the record date, and the approval process. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2019-02-12 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Daesung Microbiological Labs, covering the period from January 1, 2018, to September 30, 2018. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-13 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Daesung Microbiological Labs) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty (Public Procurement Service), and terms. Since this is a specific regulatory disclosure regarding a material business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2018-10-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.